{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:27:32Z","timestamp":1784744852746,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research","award":["20K07405"],"award-info":[{"award-number":["20K07405"]}]},{"name":"Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research","award":["22K07414"],"award-info":[{"award-number":["22K07414"]}]},{"DOI":"10.13039\/501100003806","name":"Hokuto Foundation for Bioscience","doi-asserted-by":"publisher","award":["none"],"award-info":[{"award-number":["none"]}],"id":[{"id":"10.13039\/501100003806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-024-01537-7","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T08:03:45Z","timestamp":1724832225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring LGR5 as a prognostic marker of extrahepatic cholangiocarcinoma: insights from expression analysis and clinical correlations"],"prefix":"10.1186","volume":"19","author":[{"given":"Hisashi","family":"Tamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Iwaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Asaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kamakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyoshi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"issue":"6","key":"1537_CR1","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","volume":"77","author":"M Vithayathil","year":"2022","unstructured":"Vithayathil M, Khan SA. Current epidemiology of cholangiocarcinoma in western countries. J Hepatol. 2022;77(6):1690\u20138.","journal-title":"J Hepatol"},{"issue":"2","key":"1537_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4254\/wjh.v13.i2.166","volume":"13","author":"AI Tantau","year":"2021","unstructured":"Tantau AI, Mandrutiu A, Pop A, Zaharie RD, Crisan D, Preda CM, et al. Extrahepatic cholangiocarcinoma: current status of endoscopic approach and additional therapies. World J Hepatol. 2021;13(2):166\u201386.","journal-title":"World J Hepatol"},{"issue":"2","key":"1537_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/jso.25773","volume":"121","author":"L Wu","year":"2020","unstructured":"Wu L, Merath K, Farooq A, Hyer JM, Tsilimigras DI, Paredes AZ, et al. Photodynamic therapy may provide a benefit over systemic chemotherapy among non-surgically managed patients with extrahepatic cholangiocarcinoma. J Surg Oncol. 2020;121(2):286\u201393.","journal-title":"J Surg Oncol"},{"issue":"9","key":"1537_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.4252\/wjsc.v7.i9.1185","volume":"7","author":"DL Dragu","year":"2015","unstructured":"Dragu DL, Necula LG, Bleotu C, Diaconu CC, Chivu-Economescu M. Therapies targeting cancer stem cells: current trends and future challenges. World J Stem Cells. 2015;7(9):1185\u2013201.","journal-title":"World J Stem Cells"},{"issue":"1\u20132","key":"1537_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0303-7207(99)00017-9","volume":"151","author":"T Schoneberg","year":"1999","unstructured":"Schoneberg T, Schultz G, Gudermann T. Structural basis of G protein-coupled receptor function. Mol Cell Endocrinol. 1999;151(1\u20132):181\u201393.","journal-title":"Mol Cell Endocrinol"},{"issue":"7165","key":"1537_CR6","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nature06196","volume":"449","author":"N Barker","year":"2007","unstructured":"Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449(7165):1003\u20137.","journal-title":"Nature"},{"issue":"2","key":"1537_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.clinre.2014.07.008","volume":"39","author":"Y Han","year":"2015","unstructured":"Han Y, Xue X, Jiang M, Guo X, Li P, Liu F, et al. LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: a meta-analysis. Clin Res Hepatol Gastroenterol. 2015;39(2):267\u201373.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"12","key":"1537_CR8","doi-asserted-by":"publisher","first-page":"e0168904","DOI":"10.1371\/journal.pone.0168904","volume":"11","author":"B Wang","year":"2016","unstructured":"Wang B, Chen Q, Cao Y, Ma X, Yin C, Jia Y, et al. LGR5 is a gastric Cancer stem cell marker Associated with Stemness and the EMT signature genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1. PLoS ONE. 2016;11(12):e0168904.","journal-title":"PLoS ONE"},{"issue":"1","key":"1537_CR9","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/s41467-020-15846-0","volume":"11","author":"W Cao","year":"2020","unstructured":"Cao W, Li M, Liu J, Zhang S, Noordam L, Verstegen MMA, et al. LGR5 marks targetable tumor-initiating cells in mouse liver cancer. Nat Commun. 2020;11(1):1961.","journal-title":"Nat Commun"},{"key":"1537_CR10","doi-asserted-by":"publisher","first-page":"151491","DOI":"10.1016\/j.anndiagpath.2020.151491","volume":"46","author":"S Ogasawara","year":"2020","unstructured":"Ogasawara S, Uehara T, Nakajima T, Iwaya M, Maeno K, Tsuchiya S, et al. Correlation of clinicopathological features and LGR5 expression in triple-negative breast cancer. Ann Diagn Pathol. 2020;46:151491.","journal-title":"Ann Diagn Pathol"},{"issue":"9","key":"1537_CR11","doi-asserted-by":"publisher","first-page":"e107013","DOI":"10.1371\/journal.pone.0107013","volume":"9","author":"Q Chen","year":"2014","unstructured":"Chen Q, Zhang X, Li WM, Ji YQ, Cao HZ, Zheng P. Prognostic value of LGR5 in colorectal cancer: a meta-analysis. PLoS ONE. 2014;9(9):e107013.","journal-title":"PLoS ONE"},{"issue":"6","key":"1537_CR12","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/humrep\/dey083","volume":"33","author":"N Tempest","year":"2018","unstructured":"Tempest N, Baker AM, Wright NA, Hapangama DK. Does human endometrial LGR5 gene expression suggest the existence of another hormonally regulated epithelial stem cell niche? Hum Reprod. 2018;33(6):1052\u201362.","journal-title":"Hum Reprod"},{"issue":"1","key":"1537_CR13","doi-asserted-by":"publisher","first-page":"17750","DOI":"10.1038\/s41598-021-97351-y","volume":"11","author":"HJ Lee","year":"2021","unstructured":"Lee HJ, Myung JK, Kim HS, Lee DH, Go HS, Choi JH, et al. Expression of LGR5 in mammary myoepithelial cells and in triple-negative breast cancers. Sci Rep. 2021;11(1):17750.","journal-title":"Sci Rep"},{"issue":"4","key":"1537_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/carcin\/bgt377","volume":"35","author":"D Hirsch","year":"2014","unstructured":"Hirsch D, Barker N, McNeil N, Hu Y, Camps J, McKinnon K, et al. LGR5 positivity defines stem-like cells in colorectal cancer. Carcinogenesis. 2014;35(4):849\u201358.","journal-title":"Carcinogenesis"},{"key":"1537_CR15","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. Wiley; 2017.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"issue":"2","key":"1537_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182.","journal-title":"Histopathology"},{"key":"1537_CR17","unstructured":"Surgery JSoH-B-P. General rules for clinical and pathological studies on cancer of the biliary tree (in Japanese), 7th eidtion edn. Tokyo: Kanehara Pub; 2021."},{"issue":"9","key":"1537_CR18","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.ejso.2015.05.013","volume":"41","author":"G Ercolani","year":"2015","unstructured":"Ercolani G, Dazzi A, Giovinazzo F, Ruzzenente A, Bassi C, Guglielmi A, et al. Intrahepatic, peri-hilar and distal cholangiocarcinoma: three different locations of the same tumor or three different tumors? Eur J Surg Oncol. 2015;41(9):1162\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"1537_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.17.00080","volume":"2","author":"A Jain","year":"2018","unstructured":"Jain A, Borad MJ, Kelley RK, Wang Y, Abdel-Wahab R, Meric-Bernstam F, et al. Cholangiocarcinoma with FGFR genetic aberrations: a unique clinical phenotype. JCO Precis Oncol. 2018;2:1\u201312.","journal-title":"JCO Precis Oncol"},{"issue":"6","key":"1537_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/bjs.11125","volume":"106","author":"S Otsuka","year":"2019","unstructured":"Otsuka S, Ebata T, Yokoyama Y, Mizuno T, Tsukahara T, Shimoyama Y, et al. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma. Br J Surg. 2019;106(6):774\u201382.","journal-title":"Br J Surg"},{"issue":"9","key":"1537_CR21","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1097\/PAS.0b013e318220e59d","volume":"35","author":"OC Ukpo","year":"2011","unstructured":"Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr. High-risk human papillomavirus E6\/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35(9):1343\u201350.","journal-title":"Am J Surg Pathol"},{"key":"1537_CR22","doi-asserted-by":"publisher","first-page":"8654","DOI":"10.1038\/srep08654","volume":"5","author":"AM Baker","year":"2015","unstructured":"Baker AM, Graham TA, Elia G, Wright NA, Rodriguez-Justo M. Characterization of LGR5 stem cells in colorectal adenomas and carcinomas. Sci Rep. 2015;5:8654.","journal-title":"Sci Rep"},{"key":"1537_CR23","doi-asserted-by":"crossref","unstructured":"Wu HJ, Chu PY. Role of Cancer Stem cells in Cholangiocarcinoma and therapeutic implications. Int J Mol Sci. 2019; 20(17).","DOI":"10.3390\/ijms20174154"},{"issue":"7436","key":"1537_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature11826","volume":"494","author":"M Huch","year":"2013","unstructured":"Huch M, Dorrell C, Boj SF, van Es JH, Li VS, van de Wetering M, et al. In vitro expansion of single Lgr5\u2009+\u2009liver stem cells induced by wnt-driven regeneration. Nature. 2013;494(7436):247\u201350.","journal-title":"Nature"},{"key":"1537_CR25","doi-asserted-by":"publisher","first-page":"153832","DOI":"10.1016\/j.prp.2022.153832","volume":"232","author":"T Yoshizawa","year":"2022","unstructured":"Yoshizawa T, Uehara T, Iwaya M, Asaka S, Kobayashi S, Nakajima T, et al. Correlation of LGR5 expression and clinicopathological features in intrahepatic cholangiocarcinoma. Pathol Res Pract. 2022;232:153832.","journal-title":"Pathol Res Pract"},{"key":"1537_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.humpath.2022.06.001","volume":"132","author":"Y Zen","year":"2023","unstructured":"Zen Y. Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities. Hum Pathol. 2023;132:197\u2013207.","journal-title":"Hum Pathol"},{"issue":"2","key":"1537_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","volume":"73","author":"R Montal","year":"2020","unstructured":"Montal R, Sia D, Montironi C, Leow WQ, Esteban-Fabro R, Pinyol R, et al. Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma. J Hepatol. 2020;73(2):315\u201327.","journal-title":"J Hepatol"},{"issue":"10","key":"1537_CR28","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.ajpath.2018.06.012","volume":"188","author":"BG Jang","year":"2018","unstructured":"Jang BG, Kim HS, Chang WY, Bae JM, Kim WH, Kang GH. Expression Profile of LGR5 and its prognostic significance in Colorectal Cancer Progression. Am J Pathol. 2018;188(10):2236\u201350.","journal-title":"Am J Pathol"},{"key":"1537_CR29","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1038\/ncomms4149","volume":"5","author":"C Wu","year":"2014","unstructured":"Wu C, Qiu S, Lu L, Zou J, Li WF, Wang O, et al. RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer. Nat Commun. 2014;5:3149.","journal-title":"Nat Commun"},{"issue":"23","key":"1537_CR30","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1158\/0008-5472.CAN-17-0219","volume":"77","author":"X Zhou","year":"2017","unstructured":"Zhou X, Geng L, Wang D, Yi H, Talmon G, Wang J. R-Spondin1\/LGR5 activates TGFbeta Signaling and suppresses Colon Cancer Metastasis. Cancer Res. 2017;77(23):6589\u2013602.","journal-title":"Cancer Res"},{"issue":"5","key":"1537_CR31","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.stem.2011.10.008","volume":"9","author":"EMF de Sousa","year":"2011","unstructured":"de Sousa EMF, Colak S, Buikhuisen J, Koster J, Cameron K, de Jong JH, et al. Methylation of cancer-stem-cell-associated wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell. 2011;9(5):476\u201385.","journal-title":"Cell Stem Cell"},{"key":"1537_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cellsig.2017.09.018","volume":"42","author":"ML Martin","year":"2018","unstructured":"Martin ML, Zeng Z, Adileh M, Jacobo A, Li C, Vakiani E, et al. Logarithmic expansion of LGR5(+) cells in human colorectal cancer. Cell Signal. 2018;42:97\u2013105.","journal-title":"Cell Signal"},{"issue":"6","key":"1537_CR33","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1053\/j.gastro.2020.08.016","volume":"159","author":"CC Wong","year":"2020","unstructured":"Wong CC, Xu J, Bian X, Wu JL, Kang W, Qian Y, et al. In colorectal Cancer cells with mutant KRAS, SLC25A22-Mediated glutaminolysis reduces DNA demethylation to increase WNT signaling, stemness, and Drug Resistance. Gastroenterology. 2020;159(6):2163\u2013e21802166.","journal-title":"Gastroenterology"},{"issue":"38","key":"1537_CR34","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1038\/onc.2014.416","volume":"34","author":"E Lemieux","year":"2015","unstructured":"Lemieux E, Cagnol S, Beaudry K, Carrier J, Rivard N. Oncogenic KRAS signalling promotes the Wnt\/beta-catenin pathway through LRP6 in colorectal cancer. Oncogene. 2015;34(38):4914\u201327.","journal-title":"Oncogene"},{"issue":"5","key":"1537_CR35","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.tcb.2018.01.010","volume":"28","author":"C Leung","year":"2018","unstructured":"Leung C, Tan SH, Barker N. Recent advances in Lgr5(+) stem cell research. Trends Cell Biol. 2018;28(5):380\u201391.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"1537_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12885-021-07913-6","volume":"21","author":"T Ehara","year":"2021","unstructured":"Ehara T, Uehara T, Nakajima T, Kinugawa Y, Kobayashi S, Iwaya M, et al. LGR5 expression is associated with prognosis in poorly differentiated gastric adenocarcinoma. BMC Cancer. 2021;21(1):228.","journal-title":"BMC Cancer"},{"issue":"7517","key":"1537_CR37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202\u20139.","journal-title":"Nature"},{"issue":"1","key":"1537_CR38","doi-asserted-by":"publisher","first-page":"13918","DOI":"10.1038\/s41598-022-18133-8","volume":"12","author":"SA Ebeid","year":"2022","unstructured":"Ebeid SA, Abd El Moneim NA, El-Benhawy SA, Ramadan R, Ismail SE. Znhit1 and HIF-2alpha are correlated with cancer stem cell markers in breast cancer patients. Sci Rep. 2022;12(1):13918.","journal-title":"Sci Rep"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01537-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-024-01537-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01537-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T08:15:16Z","timestamp":1724832916000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-024-01537-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1537"],"URL":"https:\/\/doi.org\/10.1186\/s13000-024-01537-7","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Shinshu University School of Medicine (Approval No: 5836). The requirement of informed consent was waived, and an opt-out method was used because of the retrospective design of the study. The investigation was conducted in compliance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}